APA citiranje

Loeb, S., Metter, E. J., Kan, D., Roehl, K. A., & Catalona, W. J. (2012). Prostate-Specific Antigen Velocity Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer.

Citação norma Chicago

Loeb, Stacy, E. Jeffrey Metter, Donghui Kan, Kimberly A. Roehl, and William J. Catalona. Prostate-Specific Antigen Velocity Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer. 2012.

MLA citiranje

Loeb, Stacy, et al. Prostate-Specific Antigen Velocity Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer. 2012.